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In the recirculating rat liver perfusion a continuous release of glutathione into the perfusion medium is ob- 
served. Addition of L-cysteine to the perfusion medium immediately arrested this glutathione efflex. The 
cysteine precursor oxothiazolidine carboxylate did not block the glutathione efllux in spite of the fact that 
it generated more L-cysteine inside the liver cells than L-cysteine itself; L-cysteine is rapidly oxidized to cys- 
tine, that is no longer taken up by the liver. The results suggest hat the inhibition of glutathione efflux 
results from the presence of cystine in the perfusion medium. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Rat liver hepatocytes continuously release 
glutathione, as observed in both the single pass 
perfused liver [1,2] and isolated hepatocytes [3,4]. 
It is mainly released as reduced glutathione (GSH), 
but this rapidly oxidizes in air to oxidized 
glutathione (GSSG). Under situations of oxidative 
stress the liver releases mainly oxidized GSSG 
[5,6]. The mechanisms of these glutathione ef- 
fluxes remain unelucidated. 
L-[%]Cysteine (spec. act. 790 Ci/mmol) was 
purchased from NEN, Dreieich. OTC was syn- 
thesized as in [8]. 
It was reported in [4] that glutathione efflux 
from isolated rat hepatocytes could be inhibited by 
methionine and some analogs; several other amino 
acids were not effective. This inhibition was not 
due to inhibition of GSH synthesis, nor was it 
dependent on Na+ , synthesis of cysteine or ATP 
generation. Here we show that cysteine has a 
similar effect, while L-2-oxothiazolidine-4-carbox- 
ylate (OTC), an intracellular L-cysteine precursor 
[7], has no such effect. 
For the recirculating, isolated rat liver perfusion 
system, male Wistar rats (260-280 g body wt) were 
used that had free access to food and water. The 
liver weight was 9.7 f 0.3 g. The perfusion system 
has been extensively described [9]. The 
erythrocyte-free perfusion medium consisted of 
Krebs-bicarbonate buffer, pH 7.4, in which 
MgS04 was replaced by MgC12, so that initially no 
sulfate was present; 1% (w/v) bovine serum 
albumin was added. Oxygenation was provided by 
carbogen gas, and the liver flow was 40 ml/min. 
After a pre-perfusion period of 30 min (employing 
100 ml perfusion medium), 1 ml of a freshly 
prepared solution of either 100 mM L-[35S]cys- 
teine, or 100 mM OTC was added. Samples of per- 
fusion medium and bile were taken during the per- 
fusions which lasted for 2-4 h. 
* To whom correspondence should be addressed Inorganic sulfate was determined as in [lo]. 
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Reduced L-cysteine was determined according to 
[ 111. Total cysteine was measured similarly after 
reduction of disulfides with dithiothreitol as in 
[ 121. GSH was determined fluorimetrically [ 131; 
total glutathione was measured similarly after 
reduction with dithiothreitol. 
3. RESULTS 
In the recirculating rat liver perfusion a steady 
increase in the glutathione concentration in the 
perfusion medium was observed, due to efflux of 
glutathione from the liver (fig.l). In this recir- 
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Fig. 1. Efflux of glutathione in the isolated recirculating 
rat liver perfusion. The livers were perfused for 3 h. 
After a pre-perfusion period of 30 min, either L-cysteine 
(~;n=3)orOTC(o----o;n=4)wereaddedtoa 
final concentration of 1 mM. Two controls (0) in which 
only solvent was added are also shown. Mean + SE is 
60 90 120 150 
time (min I 
Fig.2. Disappearance of L-cysteine from the perfusion 
medium. After a pre-perfusion of 30 min, L- 
[“S]cysteine was added to a final concentration of 
1 mM. The concentration of L-cysteine (M), total 
cyst(e)ine (mainly cystine; 0) as well as total ‘3 
shown. radioactivity (m) are given. 
culating, well oxygenated system glutathione was 
virtually exclusively present as GSSG. Glutathione 
accumulated to approx. 550pM after 3 h. When, 
after 30 min pre-perfusion, L-cysteine was added, 
there was a rapid drop in glutathione concentra- 
tion, after which it increased only very slowly for 
the next 2 h, indicating that the efflux of 
glutathione from the liver was greatly reduced 
(fig. 1). Reduced L-cysteine disappeared very 
rapidly from the perfusion medium, mainly due to 
oxidation to cystine. The cystine formed was only 
slowly taken up by the liver as determined both 
chemically and radiochemically (fig.2). Only 
reduced cysteine, present during the first few 
minutes, seemed to be taken up rapidly by the 
liver; however, relatively little became available in- 
side the hepatocytes, since no increase of inorganic 
sulfate in the perfusion medium was observed 
(fig.3). Since the effect of cyst(e)ine persisted dur- 
ing the whole perfusion we wanted to know 
whether this was an effect of cysteine (inside the 
hepatocyte) or of cystine (in the perfusion 
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Fig.3. Release of inorganic sulfate in the perfusion 
medium. The concentration of inorganic sulfate in the 
perfusion medium, which contained initially no sulfate, 
is shown. During the pre-perfusion inorganic sulfate 
leaks from the liver to equilibrium. After 30 min, either 
L-cysteine (H), OTC (0) or solvent (0) were added. 
medium). Therefore, we have also determined the 
effect of OTC, which is converted to L-cysteine in- 
side liver cells. Clearly, OTC had no effect on the 
glutathione efflux (fig. I), although it increased the 
concentration of inorganic sulfate in the perfusion 
medium considerably, in contrast to added L- 
cysteine. 
The concentration of glutathione was deter- 
mined in livers after the perfusion. The glutathione 
content of livers to which L-cysteine had been add- 
ed was (after 2.5 h perfusion) 3.10 +- O.lO,~mol/g 
liver, while in the OTC perfusions the level was 
0.72 + 0.05; in both cases approx. 90% was GSH. 
In one control perfusion the level was determined 
at 1.12 rmol/g liver, of which again 90% was 
GSH. 
4. DISCUSSION 
Our results show that either cysteine or cystine 
inhibits the efflux of glutathione from the liver, an 
effect that appears to be similar to that observed 
by authors in [4] for methionine. They found that 
the effect of methionine did not require its conver- 
sion to cysteine, but they did not test cyst(e)ine 
itself. Now fig.2 shows that within a few minutes 
L-cysteine in the perfusion medium had almost 
completely been oxidized to cysteine, while a part 
was also taken up by the liver. The fact that the in- 
hibition persisted after L-cysteine had disappeared 
suggested that either L-cysteine taken up was 
responsible for the effect, or that cysteine inhibited 
the efflux, since its concentration hardly decreased 
during the perfusion. However, because OTC had 
no effect on glutathione efflux, the inhibition is 
most likely mediated by cystine. In fact, the pro- 
duction of inorganic sulfate only after OTC in- 
dicates that more cysteine became available in the 
cell after OTC than after L-cysteine itself. Since lit- 
tle cystine is present inside the hepatocyte [14] the 
effect of cystine may be effected from the outside 
of the hepatocytes. In agreement with the data in 
[4] we found much higher GSH levels in the L- 
cysteine perfused livers than in the OTC livers 
again in spite of the fact that OTC seemed to yield 
more intracellular cysteine: due to a decreased ef- 
flux, a higher residual GSH inside the liver at the 
end of the perfusion resulted. 
The fact that we find GSSG rather than GSH in 
the perfusion medium most likely is due to the 
rapid oxidation of GSH in the well oxygenated 
recirculating perfusion medium. 
Another finding is that cysteine seems to be 
much faster taken up by the liver than cystine, an 
observation that seems not to have been reported 
before [14]; this may be related to the relatively 
low levels of y-glutamyltranspeptidase in the liver 
[15]. In recirculating perfusions, therefore, L- 
cysteine cannot be added to increase the availabili- 
ty of this amino acid, since it will be rapidly oxi- 
dized, unless an antioxidant is added as well. 
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